New Drug CagriSema May Lead to 10% More Weight Loss Than Wegovy or Ozempic
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs Ozempic and Wegovy. Novo Nordisk, the manufacturer of both, recently shared that CagriSema may lead to 10 percent more weight loss than Wegovy.
New FDA Warning Added to Popular Weight Loss Drugs
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration during general anesthesia or deep sedation. The affected drugs are liraglutide (Saxenda, Victoza), semaglutide (Ozempic, Rybelsus, Wegovy), and tirzepatide (Mounjaro, Zepbound).
How weight loss drugs took over Instagram
In one hand, a slender young woman holds up a bottle of clear liquid. The words “Skinny” and “GLP-1” — a new class of weight loss drugs — are visible on the label. In the other hand, she raises up a pipette filled with the liquid, as if to drop it in her open mouth. “Lose up to 15% of your body weight,” reads the caption on the Instagram post.
Al Roker Says He’s 'Not Gonna Judge Anybody' Taking Weight Loss Drugs: 'It’s Unlike Any Other Addiction'
“I'm not gonna judge anybody,” he told the outlet. “Listen, it's unlike any other addiction or dependence. You can live without alcohol, you can live without cigarettes, whatever that drug of choice is... but you've got to eat, and so for some people, it's just difficult.”
New health care policy changes will soon affect weight-loss drugs
Novo Nordisk (NVO) and Eli Lilly (LLY) manufacture the top three weight loss drugs on the market, but heightened demand is promoting innovation within the field and allowing cheaper competitor products to emerge.
Nurse’s death linked to approved weight-loss drug
The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the NHS. Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, over the course of about two weeks before her death on 4 September.
First death connected to weight loss jabs approved by NHS as nurse dies after two doses
Tragedy struck as Susan McGowan, a 58 year old NHS bed manager, died after taking two doses of the weight loss drug Mounjaro, which has been hailed as the "King Kong" of slimming injections. Despite being prescribed to over 250,
Nurse who tried Mounjaro becomes first confirmed UK death linked to NHS weight loss jab
Susan McGowan, 58, took just two injections before her death in September after the new generation of drugs were hailed as an answer to Britain’s obesity crisis
Novo Nordisk affirms 25% weight-loss expectation for experimental drug CagriSema
Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...
Dallas Morning News on MSN3d
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death
MONDAY, Nov. 11, 2024 (HealthDay News) -- The weight-loss drug Ozempic can help reduce stroke patients’ risk of a heart attack or death, a new study says. GLP-1 weight-loss drugs like Ozempic or SGLT2 ...
Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died
Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...
Health on MSN3h
Can This Weight Loss Drug Alleviate Knee Pain? Experts Weigh In
Fact checked by Nick Blackmer A recent study found that semaglutide, a GLP-1 weight loss drug, reduced knee pain in people with obesity and knee osteoarthritis.Experts say the reduced knee pain ...
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here's how Americans ...
Reuters on MSN6d
Analysis-Americans hungry for weight-loss drugs grapple with supply and insurance hurdles
Americans are still eagerly seeking prescriptions for Eli Lilly and Novo Nordisk's weight-loss and diabetes drugs but cannot ...